Physician profile
Ryan B Kochanski
NPI 1568809622
$34,668.27
in general payments reported to CMS, 2019-2025
32 companies · $1,838 in 2025
The $1,838 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $25K · 2021: $611 · 2022: $686 · 2023: $3,861 · 2024: $1,678 · 2025: $1,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,202 · Travel and Lodging: $2,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,201.82 |
| Travel and Lodging | $2,174.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $25,216.07 | 2019-2020 | |
| Medtronic, INC. | $1,815.38 | 2021-2025 | Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform, Kyphon Express II Kyphopak Tray |
| Clearpoint Neuro, INC. | $1,767.83 | 2023-2025 | Clearpoint |
| Brainlab, INC. | $1,438.15 | 2021-2023 | Image Guided Surgical Device |
| Boston Scientific Corporation | $1,031.27 | 2021-2025 | Vercise, General - Dbs |
| Abbott Laboratories | $536.56 | 2019-2023 | Infinity |
| Abbvie INC. | $337.49 | 2023-2024 | |
| Medical Device Business Services, INC. | $319.99 | 2019 | |
| Providence Medical Technology, INC. | $312.28 | 2025 | |
| Cerapedics INC. | $239.78 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Intrinsic Therapeutics | $167.15 | 2024 | Barricaid Acd (Annular Closure Device) |
| Insightec,INC | $159.45 | 2022 | |
| Stryker Corporation | $137.53 | 2019 | |
| Kuros Biosciences USA, INC | $126.77 | 2024 | Magnetos |
| Depuy Synthes Sales INC. | $121.23 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $116.17 | 2025 | Reactiv8 |
| Zimmer Biomet Holdings, INC. | $106.72 | 2019 | |
| Livanova USA, INC. | $97.58 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $91.02 | 2022-2023 | Briviact |
| Janssen Pharmaceuticals, INC | $90.27 | 2023 | Spravato |
| Grifols USA, LLC | $65.01 | 2024 | Gamunex-C |
| Globus Medical, INC. | $61.28 | 2021-2022 | |
| Si-Bone, INC. | $59.33 | 2025 | |
| Integra Lifesciences Corporation | $36.34 | 2021 | |
| Ge Healthcare | $35.50 | 2024 | |
| Monteris Medical Corporation | $32.98 | 2024 | Neuroblate |
| Teva Pharmaceuticals USA, INC. | $30.42 | 2023-2024 | Ajovy, Austedo Xr |
| Argenx US, INC. | $28.84 | 2024 | Vyvgart Hytrulo |
| Neurelis, INC. | $24.70 | 2023 | Valtoco |
| Neuropace, INC. | $23.06 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $22.07 | 2024 | |
| Davol INC. | $20.05 | 2023 | Avitene Ultrafoam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kochanski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.